Clinical case severe course of coronavirus infection (COVID-19) in a child
DOI:
https://doi.org/10.26641/2307-0404.2023.1.276219Ключевые слова:
coronavirus infection (COVID-19), multisystem inflammatory syndrome (MIS-C), children, intravenous immunoglobulinАннотация
A clinical case of a severe course of coronavirus infection (COVID-19) in an adolescent is described. A 15-year-old patient was admitted to the surgical department with suspicion of acute appendicitis. According to the results of the ultrasound examination of the abdomen it was decided to perform diagnostic laparoscopy, which excluded the presence of acute surgical pathology. The increase of intoxication symptoms and the data of epidemiological anamnesis, concerning the contact with patients with the catarrhal symptoms 3-4 weeks before the disease onset, were the reason for the examination for SARS-CoV-2. On the basis of a positive polymerase chain reaction for SARS-CoV-2 and existing pneumonia according to X-ray examination of the chest, the patient was transferred to an infectious disease hospital. Further examination revealed polyserositis (ascites, pleurisy); acute kidney damage (high levels of urea, creatinine, oliguria); cytolytic syndrome (increased level of aspartate aminotransferase in 1,7 times); high level of C-reactive protein and increased level of procalcitonin, which corresponded to the local infection. After the administration of the first dose of intravenous immunoglobulin the patient's condition has improved significantly. The set of symptoms of multiple organ damage in this clinical case provides grounds for differential diagnosis between coronavirus disease and multisystem inflammatory syndrome in children on the background of the coronavirus infection COVID-19. Based on the diagnostic criteria for multisystem inflammatory syndrome in children presented by the World Health Organization, the Centers for Disease Control and Prevention, the British Medical Journal, the American Academy of Pediatrics, this clinical case can be considered as multisystem inflammatory syndrome.
Библиографические ссылки
Beth FM, Friedman K. COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis. UpToDate [Internet]. 2022 Oct 27 [cited 27 Dec 2022]. Available from: https://www.uptodate.com/contents/covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-clinical-features-evaluation-and-diagnosis
Health Department-Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) in the United States [Internet]. [cited 27 Dec 2022]. Available from: https://www.cdc.gov/mis-c/cases/index.html
Multisystem inflammatory syndrome (MIS-C) [Internet]. [cited 27 Dec 2022]. Available from: https://www.cdc.gov/mis-c
Radia T, Williams N, Agrawal P, Harman K, Weale J, Cook J, et al. Multi-system inflammatory synd-rome in children & adolescents (MIS-C): A systematic review of clinical features and presentation. Pediatr Respir Rev. 2021 Jun;38:51-7. doi: https://doi.org/10.1016/j.prrv.2020.08.001
Payne AB, Gilani Z, Godfred-Cato S, Belay ED, Feldstein LR, Patel MM, et al. Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2. JAMA Netw Open. 2021;4(6):e2116420. doi: https://doi.org/10.1001/jamanetworkopen.2021.16420
Infographic: MIS-C: Multi-System Inflammatory Syndrome in U.S. Children. [Internet]. [cited 27 Dec 2022]. Available from: https://covid.cdc.gov/covid-data-tracker/#mis-national-surveillance
Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children. European Centre for Disease Prevention and Control [Internet]. Stockholm; 2020 [cited 27 Dec 2022]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-risk-assessment-paediatric-inflammatory-multisystem-syndrome-15-May 2020.pdf
Nijman RG, De Guchtenaere A, Koletzko B, Ross Russell R, Copley S, et al. Pediatric Inflam¬matory Multi-system Syndrome: Statement by the Pediatric Section of the European Society for Emergency Medicine and European Academy of Pediatrics. Front Pediatr. 2020 Aug 28;8:490. doi: https://doi.org/10.3389/fped.2020.00490
Rubens JH, Akindele NP, Tschudy MM, Sick-Sa-muels AC. Acute COVID-19 and multisystem inflam-matory syndrome in children. BMJ. 2021;372:n385. doi: https://doi.org/10.1136/bmj.n385
Multisystem Inflammatory Syndrome in Children (MIS-C) Interim Guidance: [Internet]. [cited 27 Dec 2022]. Available from: https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/multisystem-inflammatory-syndrome-in-children-mis-c-interim-guidance/
Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. Scien-tific Brief. [Internet]. Geneva: World Health Organization; 15 May 2020 [cited 27 Dec 2022]. Available from: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19
Загрузки
Опубликован
Как цитировать
Выпуск
Раздел
Лицензия
Copyright (c) 2023 Medicni perspektivi
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.